Laerdal Bangalore has joined hands with Ubiqare Health to offer doctor-driven medical care services to its employees at home. The partnership started in May 2021 during the second wave of COVID and has now extended to care for other illnesses as well.
The latest Omicron variant of COVID has created a lot of anxiety globally. The World Health Organization (WHO) has designated it as a ‘variant of concern’ and steps are being taken internationally to contain the Omicron infections. While the healthcare experts continue their research to learn more about this variant, Ubiqare Health addresses commonly asked questions about symptoms, treatment options, etc.
Ubiqare Health is selected as a finalist for its unique platform and business model that combine telemedicine, digital specialty care and last-mile clinical network. The Ubiqare model not only connects specialized medical expertise to remote patients, but also creates new livelihoods for distributed healthcare workers living in proximity to the patients at home. This network of healthcare workers, nurses and doctors augments the capacity to deliver physical care and can be scaled as per needs.
MS affects different patients differently. The symptoms and their impact on each patient will be very different While MS doesn’t impact the patient’s life expectancy, it disrupts life to a great extent With the right kind of
supportive care at home, an MS patient can experience a fulfilling life.
MS affects different patients differently. The symptoms and their impact on each patient will be very different While MS doesn’t impact the patient’s life expectancy, it disrupts life to a great extent With the right kind of
supportive care at home, an MS patient can experience a fulfilling life.
Ganesh (name changed to protect privacy), a 46-years old male had undergone 15 days of COVID-19 treatment in May 2021 during the peak of second wave. After the initial treatment, he started complaining of uneasiness in his chest by end of May 2021. He also experienced pain in his calf muscles and joints. He had lost appetite and complained of nausea. He also had bouts of headache every now and then.
The JSS Hospital, Mysore partnered with Ubiqare Health to use our tele healthcare platform to extend their care to patients beyond the hospital. The new home monitoring service of the hospital was launched recently.
The second wave of the COVID pandemic added tremendous pressure on the country’s healthcare system. The shortages of hospital beds, trained medical resources, etc. created a horrifying situation. Amidst that chaos, JSS Hospital emerged as an early adopter of a hybrid care model and a leader amongst peer hospitals.
Seetha (name changed to protect privacy), a 69 years old lady with no comorbidities tested positive for COVID-19 infection. She complained of dry cough and loss of appetite. She had no previous record of hospital admissions.
She had tested positive during the peak of the second wave. She did not meet the hospitalization criteria set by the government for COVID-19 infections. She was required to self-isolate at home. However, given her age, her family wanted medical oversight for her to ensure her recovery.
The COVID-19 pandemic created challenges and opportunities for Indian healthcare systems. The healthcare startups were quick to develop solutions for prevention, detection, disruption, management, etc. of the infection. The pandemic was a reminder that healthcare startups can help in addressing the vulnerabilities and gaps in the current healthcare system. It also reinforced the idea that telemedicine is the future of healthcare.
The new strain or COVID double mutant is thwarting containment efforts of the country and putting the existing healthcare system under tremendous stress. Given this situation, healthcare authorities are recommending mildly symptomatic and asymptomatic patients be treated under home quarantine. This makes the role of home care services more crucial than what it was during the first wave.